Well Referenced

Tag: upper respiratory tract infection

Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections

This 2012 randomized, double-blind, placebo-controlled trial evaluated the effects of daily supplementation with 250 mg of Wellmune WGP®, a yeast-derived 1,3/1,6 β-glucan, over 90 days in 100 healthy adults during peak upper respiratory tract infection (URTI) season. Participants recorded daily health logs, and URTI symptoms triggered medical assessments and blood

Read More »
June 26, 2025 No Comments

Yeast-derived β-1,3/1,6 Glucan, Upper Respiratory Tract Infection and Innate Immunity in Older Adults

This randomized, double-blind, placebo-controlled trial investigated the effects of yeast-derived β-1,3/1,6-glucan supplementation on upper respiratory tract infections (URTIs) and innate immunity in older adults. Participants aged 50–70 years received either 250 mg/day of β-glucan or a placebo for 90 days. The study found that β-glucan supplementation significantly reduced the incidence

Read More »
June 26, 2025 No Comments